CJC-1295 With DAC
Research Overview

CJC-1295 with DAC is a 30-residue GHRH analogue: tetrasubstituted GHRH(1-29) extended with a C-terminal lysine whose epsilon amino group carries an N-epsilon-3-maleimidopropionamide moiety. This reactive Drug Affinity Complex (DAC) is chemically absent from Modified GRF(1-29), sold as CJC-1295 No DAC.

Research context

Published work reports covalent albumin conjugation and prolonged in-vivo pharmacokinetics. Half-life is an in-vivo pharmacokinetic property, not an "in-vitro half-life," and it can vary by species, assay, and formulation.

Common analytical research areas
  • Albumin conjugation and long-acting peptide design.
  • GHRH-receptor signaling and pharmacokinetic modeling.
  • Comparison with non-DAC Modified GRF(1-29).
Selected scientific references

Research-use notice: Supplied exclusively for laboratory research and analytical use. Not for human or veterinary use, diagnosis, treatment, food, cosmetic, or household use.

Specification record updated 26 Sept 2026. External database links are provided for research context; verify primary sources before analytical use.

Medicine & Drugs

CJC-1295 With DAC

Overview

Long-acting growth hormone booster — steady GH release for 6–8 days per dose.

Rs. 4,999.00
Request Certificate of Analysis
Get the third-party COA for this product via WhatsApp
❯
Product Specifications
Product class Albumin-binding GHRH analogue
Identity note C-terminal N-epsilon-3-maleimidopropionamide-Lys DAC
Available sizes 5 mg, 10 mg
Purity >99% by HPLC
Intended use >Laboratory research only
Research Overview

CJC-1295 with DAC is a 30-residue GHRH analogue: tetrasubstituted GHRH(1-29) extended with a C-terminal lysine whose epsilon amino group carries an N-epsilon-3-maleimidopropionamide moiety. This reactive Drug Affinity Complex (DAC) is chemically absent from Modified GRF(1-29), sold as CJC-1295 No DAC.

Research context

Published work reports covalent albumin conjugation and prolonged in-vivo pharmacokinetics. Half-life is an in-vivo pharmacokinetic property, not an "in-vitro half-life," and it can vary by species, assay, and formulation.

Common analytical research areas
  • Albumin conjugation and long-acting peptide design.
  • GHRH-receptor signaling and pharmacokinetic modeling.
  • Comparison with non-DAC Modified GRF(1-29).
Selected scientific references

Research-use notice: Supplied exclusively for laboratory research and analytical use. Not for human or veterinary use, diagnosis, treatment, food, cosmetic, or household use.

Specification record updated 26 Sept 2026. External database links are provided for research context; verify primary sources before analytical use.

Uses

Muscle growth and recovery

Growth hormone support

Support body composition

Research use Laboratory supply only
Batch verified COA per batch, always
India dispatch Secure checkout and tracking

You may also like